Shineco, Inc. logo
Shineco, Inc. TYHT

Shineco, Inc. EV - Enterprise Value | TYHT

Annual EV - Enterprise Value Shineco, Inc.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
22.9 B 18.9 B - 21.3 B 24.9 B 17.7 B 21.7 B - 17.8 B 17.1 B 19.4 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
24.9 B 17.1 B 20.2 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer EV - Enterprise Value Price % 24h Market Cap Country
Omeros Corporation Omeros Corporation
OMER
661 M $ 13.23 -5.71 % $ 840 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
5.66 B $ 0.94 -10.44 % $ 2.32 B israelIsrael
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
226 M - 7.4 % $ 6.29 M usaUSA
Forma Therapeutics Holdings Forma Therapeutics Holdings
FMTX
452 M - - $ 958 M usaUSA
Blueprint Medicines Corporation Blueprint Medicines Corporation
BPMC
6.74 B - - $ 8.14 B usaUSA
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
22.9 B - - $ 26.6 B irlandaIrlanda
Provention Bio Provention Bio
PRVB
1.86 B - - $ 2.37 B usaUSA
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
1.6 B - - $ 6.29 B usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
1.3 M $ 0.47 -24.53 % $ 305 K israelIsrael
iTeos Therapeutics iTeos Therapeutics
ITOS
248 M - - $ 411 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
-721 K $ 1.44 -2.03 % $ 2.37 M israelIsrael
PolarityTE PolarityTE
PTE
-900 K - -0.82 % $ 1.78 M usaUSA
Kronos Bio Kronos Bio
KRON
-47.8 M - 1.49 % $ 50.8 M usaUSA
Cullinan Management Cullinan Management
CGEM
850 M $ 8.9 -1.93 % $ 536 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
4.38 B $ 39.15 0.57 % $ 3.52 B schweizSchweiz
Advaxis Advaxis
ADXS
-3.02 M - -9.65 % $ 45.9 M usaUSA
Stoke Therapeutics Stoke Therapeutics
STOK
1.99 B $ 26.77 -0.59 % $ 1.59 B usaUSA
Trevena Trevena
TRVN
20.4 M - -46.58 % $ 31.8 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
-17.2 M - -10.95 % $ 876 K usaUSA
Molecular Templates Molecular Templates
MTEM
29.7 M - -23.43 % $ 495 K usaUSA
Oncorus Oncorus
ONCR
59.4 M - -8.54 % $ 3.19 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
127 M $ 0.07 9.81 % $ 855 K usaUSA
Novan Novan
NOVN
99.6 M - -24.84 % $ 2.64 M usaUSA
CohBar CohBar
CWBR
410 K - -15.44 % $ 2.2 M usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
-3.75 M - -1.56 % $ 12.3 M usaUSA
Epizyme Epizyme
EPZM
27.9 M - - $ 249 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
5.42 B - -6.81 % $ 3.04 B usaUSA
Scopus BioPharma Scopus BioPharma
SCPS
3.67 M - -48.37 % $ 3.71 M usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
20.2 M - - $ 4.55 M irlandaIrlanda
Annovis Bio Annovis Bio
ANVS
36.5 M $ 0.71 -3.81 % $ 14.6 M usaUSA
scPharmaceuticals scPharmaceuticals
SCPH
18.5 M - - $ 218 M usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
51.1 M - - $ 105 M usaUSA
Athersys Athersys
ATHX
-9.04 M - 3.77 % $ 22.4 M usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
1.87 B - - $ 4.62 B usaUSA
Inozyme Pharma Inozyme Pharma
INZY
44.3 M - - $ 207 M usaUSA
NanoString Technologies NanoString Technologies
NSTG
655 M - -37.43 % $ 5.1 M usaUSA
Humanigen Humanigen
HGEN
60.3 M - -81.12 % $ 4.28 M usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
-2.04 M $ 3.56 -9.07 % $ 1.58 M usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
471 M - -29.58 % $ 126 M usaUSA
Surface Oncology Surface Oncology
SURF
-40 B - - $ 59.7 M usaUSA
Sierra Oncology Sierra Oncology
SRRA
197 M - -0.05 % $ 1.34 B canadaCanada
Vaccinex Vaccinex
VCNX
6.94 M - -61.37 % $ 654 K usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
26.1 M - -19.68 % $ 18.4 M canadaCanada
Jounce Therapeutics Jounce Therapeutics
JNCE
-73.6 M - - $ 98.4 M usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
7.76 M $ 0.93 -4.11 % $ 10.5 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
122 M $ 1.89 6.78 % $ 52.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-13.2 M - -24.86 % $ 820 K usaUSA
Longeveron Longeveron
LGVN
16.9 B $ 1.65 -9.34 % $ 29 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-1.05 M - -11.43 % $ 502 K usaUSA
Immunic Immunic
IMUX
160 M $ 7.0 -5.28 % $ 1.09 B usaUSA